John Lansing's Trending123
John Lansing's Trending123
Username: Password: Login
Trade Talk E-Letter Products & Services Trading Tools Portfolios Members Home
Enter Symbol:
WARNER CHILCOTT LIMITED
Drug Manufacturers Other
WCRX @ Yahoo Finance
WCRX Option @ Yahoo Finance
Stock Details
Current Price High Value Change Percent Change Dividend Previous Close
$ 16.20 $ 16.27 $ -0.09 -0.55% 0.00 $ 16.29
Opening Price Low Volume Market Cap Average Volume P/E
$ 16.18 $ 15.85 459,665 4.06B 473,283 43.78
Pivot Table
R2 R1 Pivot S1 S2
16.53 16.37 16.11 15.95 15.69

stock chart

Warner Chilcott Limited, a specialty pharmaceutical company, engages in the development, manufacture, marketing, and sale of branded prescription pharmaceutical products in women's healthcare and dermatology primarily in the United States. It offers various women healthcare products, including LOESTRIN 24 FE, OVCON 50, and FEMCON FE to prevent pregnancy; ESTROSTEP FE to prevent pregnancy and treat moderate acne in women, who desire oral contraception; FEMHRT 1/5 and .5/2.5 Oral to treat moderate to severe vasomotor symptoms and urogenital symptoms associated with menopause; and ESTRACE cream to treat vaginal and vulvar atrophy. The company also offers various dermatology products, such as TACLONEX and DOVONEX for the topical treatment of psoriasis; and DORYX, an oral adjunctive therapy for severe acne. In addition, its products under development include WC2061, an oral contraceptive, which is in a phase II pilot study; WC3016, an oral contraceptive that is in Phase III development stage; WC3026, an oral contraceptive which has completed Phase II stage; GD1105, a contraceptive vaginal ring that is in the preclinical phase; WC3018, which is in the preclinical phase for the treatment of acne and other inflammatory skin conditions; TD1414, a topical antibiotic for skin infections that is in late preclinical phase; WC2063, which is in the preclinical stage of development; LEO 80-185 that has completed Phase III to treat psoriasis of the scalp and body; LEO 80-190, which has completed Phase II stage for the topical treatment for psoriasis; and WC3027 that is in the preclinical phase for the treatment of inflammatory skin conditions. Its principal customers include wholesale pharmaceutical distributors, and major retail drug and grocery store chains. Warner Chilcott has license and supply agreement with LEO Pharma A/S. The company was founded in 1968 and is headquartered in Rockaway, New Jersey.

  • Premarket, intraday, nightly, and weekend updates, which include stock picks with full instructions, market direction (short, intermediate, long term), precious metal, commodity, and currency analysis.
  • Provide you stock picks (breakouts) and market direction to help you become
    more profitable.

  • Voice over chart updates sent to you by e-mail. These updates contain stock picks and market status for a number of different portfolios, which Trending123 is recommending and following.
  • Instantaneous e-mail alerts during the trading day when targets have been hit or the status of a position or the market warrants a move. Stock Recommendations for swing traders, day traders, and long term investors.
  • Receive instant emails to your computer, organizer, cell phone of breakouts on stocks.....Learn More